Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Uterine Cervical Neoplasms 3Ganglioneuroblastoma 3Sarcoma, Ewing 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Vaginal Neoplasms 1Stomach Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Polycystic Ovary Syndrome 1Oropharyngeal Neoplasms 1Multiple Myeloma 1Locally Advanced Cervical Adenocarcinoma 1Infertility 1Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1Cholangiocarcinoma 1Cervical Adenocarcinoma 1Carcinosarcoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Biochemically Recurrent Prostate Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

olaparib 1durvalumab 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Immunoglobulin G 1Disulfides 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biochemically Recurrent Prostate Carcinoma × Congresses as Topic × 1 year × Clear all
NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡